AKRO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Akero Therapeutics (AKRO) Earnings Date & Reports

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AKRO is expected to report earnings to rise 3.73% to -93 cents per share on August 08

Akero Therapeutics AKRO Stock Earnings Reports

Q2'25

Est.

$-0.93

Q1'25

Beat

by $0.11

Q4'24

Beat

by $0.17

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.02

The last earnings report on May 13 showed earnings per share of -89 cents, beating the estimate of -100 cents. With 1.31M shares outstanding, the current market capitalization sits at 3.10B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

AKRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKRO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AKRO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

601 Gateway Boulevard

Phone

+1 650 487-6488

Employees

Web

https://www.akerotx.com